Atlas Trials

Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease

Clinical trial NCT06287086 · UNKNOWN

Trial details

NCT number
NCT06287086
Sponsor
Bioray Laboratories
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2024-06-14
Primary completion
2025-08-20
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.